A LinkedIn post from Isomorphic Labs indicates the company plans to engage with talent at the ICLR conference in Rio de Janeiro from April 23–27. The post highlights that the company is seeking machine learning engineers and research scientists at various levels for roles in London and Lausanne.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests a continued build-out of Isomorphic Labs’ technical workforce focused on frontier AI for drug discovery, including work on historically undruggable diseases. For investors, this emphasis on recruiting specialized AI talent may signal ongoing R&D investment, an expansion of internal capabilities, and a long-term commitment to scaling its platform in a competitive AI-driven biopharma landscape.

